flecainide has been researched along with Day Blindness in 4 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with paroxysmal atrial fibrillation (PAF) are prone to recurrence." | 6.67 | A randomized double-blind crossover study comparing the efficacy and tolerability of flecainide and quinidine in the control of patients with symptomatic paroxysmal atrial fibrillation. ( Lau, CP; Leung, WH; Wong, CK, 1992) |
| "Patients with paroxysmal atrial fibrillation (PAF) are prone to recurrence." | 2.67 | A randomized double-blind crossover study comparing the efficacy and tolerability of flecainide and quinidine in the control of patients with symptomatic paroxysmal atrial fibrillation. ( Lau, CP; Leung, WH; Wong, CK, 1992) |
| "Flecainide seems to be a safe drug with minimal ocular adverse effects." | 1.31 | Adverse ocular effects of flecainide. ( Ikäheimo, K; Kettunen, R; Mäntyjärvi, M, 2001) |
| " The most frequently reported extracardiac adverse experiences were dizziness (30%) and visual disturbances (28%), often occurring in tandem." | 1.27 | Extracardiac adverse effects of flecainide. ( Gentzkow, GD; Sullivan, JY, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gentzkow, GD | 1 |
| Sullivan, JY | 1 |
| Ikäheimo, K | 1 |
| Kettunen, R | 1 |
| Mäntyjärvi, M | 1 |
| Lau, CP | 1 |
| Leung, WH | 1 |
| Wong, CK | 1 |
| Nestico, PF | 1 |
| Morganroth, J | 1 |
1 trial available for flecainide and Day Blindness
| Article | Year |
|---|---|
A randomized double-blind crossover study comparing the efficacy and tolerability of flecainide and quinidine in the control of patients with symptomatic paroxysmal atrial fibrillation.
Topics: Adult; Aged; Atrial Fibrillation; Chi-Square Distribution; Double-Blind Method; Electrocardiography, | 1992 |
3 other studies available for flecainide and Day Blindness
| Article | Year |
|---|---|
Extracardiac adverse effects of flecainide.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dizziness; Dyspnea; Flecainide; Headache; Humans; Naus | 1984 |
Adverse ocular effects of flecainide.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Color Perception; Contrast Sensitivity; Eye; Female; Flecainide | 2001 |
Flecainide: a new antiarrhythmic agent.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Dizziness; Electrophysiology; Flecainide; Hemody | 1986 |